Norway's Observe Medical H2 UnoMeter revenue up 69%

Observe Medical ASA

27/02/2026 10:51

Overview

Norway medtech firm's UnoMeter revenue grew 69% in H2 2025

Company raised NOK 58.5 mln through private placements and subsequent offering

Recorded NOK 41.7 mln impairment loss for Biim Ultrasound in 2025

Outlook

Observe Medical plans to launch UnoMeter Safeti Max in March/April 2026

Company estimates global market value of new products at NOK 1.6-1.8 bln

Observe Medical strengthens liquidity with NOK 15 mln loan from Innovation Norway

Result Drivers

UNOMETER REVENUE GROWTH - UnoMeter portfolio revenues increased by 69% in H2 2025, driven by product innovation and market expansion

CAPITAL RAISE - Co raised NOK 58.5 mln through private placements and subsequent offering, enhancing financial stability

PRODUCT PORTFOLIO EXPANSION - Co plans to launch 3 new products in the urological drainage segment, targeting a market value of NOK 1.6-1.8 bln

Company press release: ID:nWkr8tsrzW

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
H2 UnoMeter Revenue
NOK 7.5 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)